Pα+ Psychedelic Patent Analysis (October 2023)
- General Overview
- Key Terms
- MindMed Scores Psilocybin-Antidepressant Co-Treatment Patent
- A Spate of PCTs Published from GH Research
- Early Fruits of Cybin’s Small Pharma Acquisition
Written by Psychedelic Alpha’s Noah Smith with support from Editor-at-Large and patent attorney Graham Pechenik of Calyx Law.
Our monthly Psychedelic Patent Analysis provides headline figures regarding published psychedelic patent applications and grants, before diving into commentary on a select handful of patent-related actions.
Note: the monthly Psychedelic Patent Analysis is a Pα+ subscriber benefit (join today). Given that this is a new format, we’re making this first issue available without a paywall...
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks
Already a member?
Sign In